Valeant Pharmaceuticals International – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from 8-K 12 pages First Supplemental Indenture

from 8-K 130 pages Valeant Pharmaceuticals International 6.75% Senior Notes Due 2017 7.00% Senior Notes Due 2020 Indenture Dated as of September 28, 2010 the Bank of New York Mellon Trust Company, N.A., as Trustee

from 8-A12B/A 3 pages Amendment No. 3 to Rights Agreement

from 8-A12B/A 3 pages Amendment No. 2 to Rights Agreement

from 8-K 4 pages Amendment No. 1 to Rights Agreement

from 8-A12B/A 4 pages Amendment No. 1 to Rights Agreement

from S-4 ~20 pages Indenture or similar

from S-4 >50 pages Indenture or similar

from 8-K >50 pages Indenture or similar

from S-3 ~20 pages Amended and Restated Bylaws

from S-3 ~20 pages Amwnded and Restated Bylaws

from S-3 1 page Specimen Stock Certificate

from S-3 ~20 pages Registration Rights Agreement

from S-3 >50 pages Indenture or similar

from 10-K/A ~5 pages Indenture or similar

from 10-K/A ~5 pages Indenture or similar

from S-4 ~20 pages Form of Letter of Transmittal

from S-4 ~20 pages Registration Rights Agreement Dtd August 20, 1998

from S-4 >50 pages Indenture Dated as of August 20, 1998

from S-4/A ~20 pages Form of Letter of Transmittal & Notice of Delivery